Clopidogrel and membranous nephropathy

Membranous nephropathy with nephrotic syndrome occurred in a patient with anterior myocardial infarction 2 months after the start of clopidogrel treatment. Sensitisation by prior treatment with ticlopidine is discussed.

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 354; no. 9188; pp. 1443 - 1444
Main Authors Tholl, U, Anlauf, M, Helmchen, U
Format Journal Article
LanguageEnglish
Published London Elsevier Ltd 23.10.1999
Lancet
Elsevier Limited
Subjects
Biological and medical sciences
Drug toxicity and drugs side effects treatment
Glomerulonephritis, Membranous - chemically induced
Glomerulonephritis, Membranous - pathology
Heart attacks
Humans
Kidneys
Male
Medical sciences
Membranes
Middle Aged
Myocardial infarction
Pharmacology. Drug treatments
Platelet Aggregation Inhibitors - adverse effects
Side effects
Ticlopidine - adverse effects
Ticlopidine - analogs & derivatives
Toxicity: urogenital system
Glomerulonephritis
Kidney disease
Human
Urinary system disease
Infarct
Toxicity
Cardiovascular disease
Nephrotic syndrome
Coronary heart disease
Myocardial disease
Antiplatelet agent
Case study
Concomitant disease
Chemotherapy
Treatment
Myocardium
Clopidogrel
Membranous glomerulonephritis
Diagnosis
Online AccessGet full text

Cover

More Information
Summary:Membranous nephropathy with nephrotic syndrome occurred in a patient with anterior myocardial infarction 2 months after the start of clopidogrel treatment. Sensitisation by prior treatment with ticlopidine is discussed.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(99)02586-6